This topic contains a solution. Click here to go to the answer

Author Question: The General Fund transfers 25,000 withheld from employee's gross pay during the last quarter to the ... (Read 57 times)

bb

  • Hero Member
  • *****
  • Posts: 544
The General Fund transfers 25,000 withheld from employee's gross pay during the last quarter to the Pension Trust Fund. Which of the following statements regarding this transaction is true?
 
  A. The General Fund will reduce a liability and the Pension Trust Fund will record additions.
  B. The General Fund will report expenditures and the Pension Trust Fund will record revenues.
  C. The General Fund will report expenditures and the Pension Trust Fund will record additions.
  D. The General Fund will reduce a liability and the Pension Trust Fund will record revenues.

Question 2

A company receives 360 for a 12-month trade magazine subscription on August 1 . The adjusting entry on December 31 is a debit to Unearned Subscription Revenue, 150, and credit to Subscription Revenue, 150.
 a. True
  b. False
 
   Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joewallace

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

A

Answer to Question 2

True





 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library